MENU
+Compare
ATHA
Stock ticker: NASDAQ
AS OF
Sep 17 closing price
Price
$0.38
Change
-$0.00 (-0.00%)
Capitalization
15.05M

ATHA Athira Pharma Forecast, Technical & Fundamental Analysis

Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration... Show more

ATHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ATHA with price predictions
Sep 17, 2025

Momentum Indicator for ATHA turns negative, indicating new downward trend

ATHA saw its Momentum Indicator move below the 0 level on August 28, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 93 similar instances where the indicator turned negative. In of the 93 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 52 cases where ATHA's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for ATHA turned negative on August 28, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at .

ATHA moved below its 50-day moving average on September 08, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ATHA crossed bearishly below the 50-day moving average on September 10, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ATHA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ATHA's RSI Oscillator exited the oversold zone, of 37 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The 50-day moving average for ATHA moved above the 200-day moving average on September 16, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ATHA advanced for three days, in of 264 cases, the price rose further within the following month. The odds of a continued upward trend are .

ATHA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.660) is normal, around the industry mean (19.637). P/E Ratio (0.000) is within average values for comparable stocks, (53.583). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.168). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (331.570).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ATHA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ATHA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
ATHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ATHA is expected to report earnings to fall 27.78% to -12 cents per share on November 06

Athira Pharma ATHA Stock Earnings Reports
Q3'25
Est.
$-0.13
Q2'25
Beat
by $0.04
Q1'25
Missed
by $0.05
Q4'24
Est.
$-0.38
Q3'24
Missed
by $0.05
The last earnings report on August 07 showed earnings per share of -18 cents, beating the estimate of -21 cents. With 162.10K shares outstanding, the current market capitalization sits at 15.05M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
18706 North Creek Parkway
Phone
+1 425 620-8501
Employees
67
Web
https://www.athira.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMZE2.740.20
+7.87%
Amaze Holdings Inc
BRZE31.930.79
+2.54%
Braze
SYF74.820.29
+0.39%
Synchrony Financial
ACU40.71-0.58
-1.40%
Acme United Corp
MNMD9.57-0.14
-1.44%
Mind Medicine (MindMed)

ATHA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ATHA has been loosely correlated with CDXS. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if ATHA jumps, then CDXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATHA
1D Price
Change %
ATHA100%
-0.97%
CDXS - ATHA
36%
Loosely correlated
-5.62%
ALNY - ATHA
35%
Loosely correlated
-2.06%
OGEN - ATHA
35%
Loosely correlated
-3.08%
IPSC - ATHA
33%
Poorly correlated
+1.37%
CRSP - ATHA
32%
Poorly correlated
-3.46%
More